Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10052540HBVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS30011493HIVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS30080005HIVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS30028905HIVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS30019971HIVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS30028906HIVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20006173HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20006206HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20042606HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TVIS20049569HPVENSG00000053918.20protein_codingKCNQ1NoNo3784P51787
TCGA Plot Options
Drug Information
GeneKCNQ1
DrugBank IDDB11633
Drug NameIsavuconazole
Target IDBE0000672
UniProt IDP51787
Regulation Typeinhibitor
PubMed IDs28074556
CitationsKeirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, Schneidkraut MJ, Townsend R, Wojtkowski T, Yamazaki T, Yen M, Kowey PR: QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization. Clin Pharmacol Ther. 2017 Jun;101(6):782-790. doi: 10.1002/cpt.620. Epub 2017 Feb 13.
GroupsApproved; Investigational
Direct ClassificationPhenylpropanes
SMILESC[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Pathways
PharmGKB
ChEMBLCHEMBL409153